Recombinant Microorganism Quantum Dot Biosynthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing quantum dots are costly and inefficient, and existing biological treatment methods for heavy metals lack effectiveness in producing stable and permeable nanomaterials for in vivo applications.

Innovation Solution

A method involving the use of a recombinant microorganism transformed with a gene encoding a heavy metal-binding protein, such as phytochelatin synthase or metallothionein, is cultured in a heavy metal ion-containing medium to produce nanoparticles, which are then collected and can be further modified for improved properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical synthesis methods are used to produce quantum dots, then production cost and efficiency are improved, but optical stability and in vivo permeability deteriorate

Engineering Contradiction:
Improveproduction efficiencyVSAvoidoptical stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent uses biological systems (microorganisms expressing metal-binding proteins) as an intermediary between chemical synthesis and biological applications. The microorganisms produce quantum dots with inherent biocompatibility while maintaining production efficiency, serving as a mediator that bridges the gap between chemical production methods and biological application requirements.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the production parameters from purely chemical synthesis to a biological production system using recombinant microorganisms. This parameter change enables simultaneous achievement of high production efficiency and excellent optical stability, as the biological system naturally produces quantum dots with stable optical properties suitable for in vivo applications.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional quantum dot production methods are used, then manufacturing simplicity is improved, but in vivo permeability and stability deteriorate

Engineering Contradiction:
Improvemanufacturing simplicityVSAvoidin vivo permeability
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent replaces conventional chemical synthesis mechanisms with biological production mechanisms. By using microorganisms that naturally synthesize and secrete quantum dots, the method achieves both manufacturing simplicity and enhanced in vivo permeability, as the biological system inherently produces biocompatible nanomaterials without requiring complex surface modification protocols.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If quantum dots are produced for in vivo applications, then optical stability is improved, but production cost and complexity increase

Engineering Contradiction:
Improveoptical stabilityVSAvoidproduction complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs self-service principles by utilizing the microorganism's own metabolic pathways and protein expression systems to produce quantum dots. The recombinant microorganisms automatically synthesize metal-binding proteins that facilitate quantum dot formation and secretion, eliminating the need for complex external synthesis equipment and procedures while maintaining high optical stability for in vivo applications.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the economical production of quantum dots with enhanced optical stability and in vivo permeability, enabling their use in biosensors and optical imaging applications.

Implementation Method 1

a method for preparing heavy metal nanoparticles using a heavy metal-binding protein

Methodology Applied
Scientific EffectMetal binding: Adsorption

Implementation Method 2

culturing a microorganism, which is transformed with a gene encoding a heavy metal-binding protein, in a heavy metal ion-containing medium, to produce heavy metal structures in the microorganism

Methodology Applied
Scientific EffectBiosynthesis:

Data Source

PatentUS8476055B2Method for preparing metal nanoparticle using metal binding protein
Publication Date: 2013.07.02 KOREA ADVANCED INST OF SCI & TECH
  • US8476055B2 patent drawing
  • US8476055B2 patent drawing
  • US8476055B2 patent drawing

AI summary

The present invention relates to a method of preparing heavy metal nanoparticles using a heavy metal-binding protein. More specifically, relates to a method for preparing heavy metal structures, comprising the steps of: culturing a microorganism transformed with a gene encoding a heavy metal-binding protein, in a heavy metal ion-containing medium, to produce heavy metal structures in the microorganism; and collecting the produced heavy metal structures, as well as nanoparticles of heavy metal structures prepared according to said method. Unlike prior methods of preparing quantum dots by physically binding metal materials, the quantum dots disclosed herein can be efficiently produced by expressing the heavy metal-binding protein in cells. In addition, the quantum dots are useful because they can solve an optical stability problem that is the shortcoming of organic fluorophores.